Spinal muscular atrophy: A preliminary result toward new therapy
- PMID: 26865521
- DOI: 10.1212/WNL.0000000000002453
Spinal muscular atrophy: A preliminary result toward new therapy
Comment on
-
Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.Neurology. 2016 Mar 8;86(10):890-7. doi: 10.1212/WNL.0000000000002445. Epub 2016 Feb 10. Neurology. 2016. PMID: 26865511 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical